Lasmiditan (Reyvow)
Lasmiditan (Reyvow) is a new medication for the treatment of acute migraine attacks. It belongs to a class of drugs called serotonin (5-HT) 1F receptor agonists, which work by activating a specific type of serotonin receptor in the brain and reducing the transmission of pain signals. Unlike other migraine medications, such as triptans, lasmiditan does not constrict blood vessels and is therefore considered safer for people with cardiovascular risk factors.
Lasmiditan was approved by the US Food and Drug Administration (FDA) in October 2019 and by the European Medicines Agency (EMA) in July 2020. It is available as an oral tablet in doses of 50 mg, 100 mg, and 200 mg. The recommended dose is 50 mg or 100 mg, depending on the severity of the migraine and the individual response. The dose can be repeated after two hours if the migraine persists or returns, but the maximum daily dose is 200 mg.
Lasmiditan is effective in relieving migraine pain, nausea, sensitivity to light and sound, and disability within two hours of taking it. It also improves the quality of life and satisfaction of migraine patients. However, lasmiditan can cause some side effects, such as drowsiness, dizziness, fatigue, tingling sensations, nausea, and dry mouth. Therefore, it is advised not to drive or operate machinery for at least eight hours after taking lasmiditan.
Lasmiditan is a promising option for people who suffer from frequent or severe migraines and who cannot take or tolerate other migraine medications. However, lasmiditan is not widely available or affordable in many countries. As an exporter based in UAE, we offer high-quality lasmiditan products at competitive prices to the world market. We have a reliable supply chain and a fast delivery service to ensure that our customers receive their orders on time and in good condition.
The table below shows the price of lasmiditan in different countries with references:
| Country | Price per tablet (USD) | Reference |
|---|---|---|
| USA | 96.77 | GoodRx |
| UK | 76.32 | Medicines.org.uk |
| Canada | 69.23 | Canada Drugs Direct |
| Australia | 63.45 | NPS MedicineWise |
| India | 15.38 | Medindia |
Table title: Price of lasmiditan in different countries
If you are interested in buying lasmiditan from us, please contact us for more information and a free quote. We are happy to answer any questions you may have and to provide you with the best service possible.
Lasmiditan is one of the top five global brands for migraine treatment, along with rimegepant (Nurtec ODT), ubrogepant (Ubrelvy), erenumab (Aimovig), and fremanezumab (Ajovy). These brands are all innovative and effective solutions for migraine patients who need fast and long-lasting relief.